With $3.82 million in second round investment funding, BioVigilant Systems is moving ahead with plans to manufacture its instantaneous microbial detection instruments for use in pharmaceutical production.
The company is now in discussions with a consortium of drug makers that includes Alcon, Amgen, Bayer, DSM Pharmaceuticals, Eli Lilly, Genentech, GlaxoSmithKline and Johnson & Johnson. The consortium is testing the detectors for use in preventing contamination at critical points in the production process.
|
|
BioVigilant, 2005 W. Ruthrauff Road, is also exploring the Asian market. Chief Executive Officer Dewey Manzar said he has been meeting with pharmaceutical makers and optical system manufacturers in Japan, "where we’ve found a very good reception."
Comments
WEL wrote on Aug 12, 2008 1:16 PM:
I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS.
Two days later I was BLIND
Use Google and enter EPOCRATES MAXIDEX to verify "